Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Chiquita BrooksLaSure

White House rule would expand coverage of anti-obesity drugs - Roll Call

It’s unclear whether incoming President Donald J. Trump will support outgoing President Joe Biden’s plan to insure the weight loss drugs.

Roll Call

Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.

Upcoming changes to the Part D drug benefit, including a $2,000 cap on out-of-pocket medication, will benefit millions of Americans. But higher premiums may also be on the way

Kiplinger

Matt Gaetz gives Medicare administrator hard deadline to provide documents about price increases

The Florida Rep. claims that the "Biden-Harris administration is hiding critical data from senior citizens to cover up their failed policies in an election year"

Latin Times

From analysis to the latest developments in health,
read the most diverse news in one place.

For CMS administrator, a focus on maternal health - Roll Call

CMS Administrator Chiquita Brooks-LaSure said she’s focusing on policies aimed at improving maternal health, be it pre- or postpartum.

Roll Call

Biden officials keep states waiting on expanding Medicaid voter registration

Officials in Oregon, Colorado and other states are waiting for Biden officials to approve plans to automatically register hundreds of thousands of eligible voters when they apply for Medicaid.

WEKU

Medicare Advantage keeps growing. Tiny, rural hospitals say that's a huge problem

More than half of seniors choose private Medicare Advantage plans instead of traditional Medicare. As rural enrollment increases, many small-town hospitals say that threatens their viability.

WEKU

Miracle new Alzheimer's drug which slows cognitive decline of disease to be rolled out

The Food and Drug Administration (FDA) has approved the much awaited drug Leqembi which has been shown to slow the cognitive decline caused by Alzheimer’s, the most common type of dementia

Daily Mirror

Read news from The Economist, FT, and more,
with one subscription

FDA fully approves new Alzheimer’s drug to slow down disease progression

‘Today’s action is first verification that a drug targeting underlying disease process has shown clinical benefit’

The Independent UK

US government approves Alzheimer’s drug to slow cognitive decline

Some insurances, including the government-run Medicare, refused to pay for the drug until it received full approval.

Al Jazeera

How Xavier Becerra went from working construction in Sacramento to launching Obamacare

WASHINGTON — “Ex-zavey-err Becerra,” an elementary school teacher called out in 1960s Sacramento.

McClatchy Washington Bureau

Affordable Care Act’s no-cost contraception rule would be bolstered under Biden move

The proposed rule would remove an employer’s ability to object to no-cost contraceptive coverage under the Affordable Care Act on moral grounds.

Chicago Sun-Times

Medicare surprise: Drug plan prices touted during open enrollment can rise within a month

Something strange happened between the time Linda Griffith signed up for a new Medicare prescription drug plan during last fall’s enrollment period and when she tried to fill her first prescription in January.

Tribune News Service

Drug plan prices touted during Medicare open enrollment can rise within a month

Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.

People

Chiquita BrooksLaSure

13 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

the Department of Health and Human Services

Centers for Medicare and Medicaid Services

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.